Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

First digital medicine approved in the US

The antipsychotic drug has a built-in digital tracking sensor

- PMLiVE

Boehringer claims EU okay for Humira biosimilar

But won’t launch before expiration of the respective SPC for adalimumab in October 2018

- PMLiVE

Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites

- PMLiVE

Zelluna appoints Miguel Forte as CEO

He joins the Norwegian biotech from Bone Therapeutics

- PMLiVE

Storm Therapeutics strengthens its board

Professor Paul Workman joins as an independent director

- PMLiVE

If a nudge doesn’t last forever, how do we ensure sustained behaviour change?

Changing behaviour isn’t easy, but maintaining behaviour change is even harder.We know that by the tiny number of New Year’s resolutions we actually manage to keep, the number of gym...

AstraZeneca AZ

AZ severe asthma drug benralizumab backed by CHMP

The IL-5 inhibitor set for European approval to treat severe eosinophilic asthma

- PMLiVE

Dynavax receives FDA green light for hepatitis B vaccine

Heplisav-B becomes first and only two-dose hep B vaccine approved in the US

- PMLiVE

Ex-GSK head Witty to head group overseeing UK fast-track scheme

Medicines selected for the AAP could be made available much earlier

- PMLiVE

Good Relations appoints new executive director

Sophie Taylor-Roberts will head the agency’s health and wellbeing practice

- PMLiVE

Lucid launches rare and specialist disease agency

Vivid MedComms will be headed by Alison Cantle

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links